Analysis of a neutralizing antibody for human herpesvirus 6B reveals a role for glycoprotein Q1 in viral entry

Journal of Virology

Volumn 85, Issue 24, 2011, Pages 12962-12971

  Kawabata, Akiko ^a,b   Oyaizu, Hiroko ^a,b   Maeki, Takahiro ^a,b   Tang, Huamin ^a,b   Yamanishi, Koichi ^b   Mori, Yasuko ^a,b  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLYCOPROTEIN; GLYCOPROTEIN Q1; GLYCOPROTEIN Q2; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RECEPTOR;

ANTIBODY SPECIFICITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; IMMUNOREACTIVITY; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; VIRUS ENTRY;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; EPITOPES, B-LYMPHOCYTE; GLYCOPROTEINS; HERPESVIRUS 6, HUMAN; HUMANS; MUTANT PROTEINS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; VIRAL PROTEINS; VIRUS INTERNALIZATION;

HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 6B;

EID: 84855833074     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05622-11     Document Type: Article

References (49)

1. Ablashi, D. V., et al. 1991. Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates. Virology 184:545-552.
2. Akhtar, J., and D. Shukla. 2009. Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry. FEBS J. 276:7228-7236.
3. Akkapaiboon, P., Y. Mori, T. Sadaoka, S. Yonemoto, and K. Yamanishi. 2004. Intracellular processing of human herpesvirus 6 glycoproteins Q1 and Q2 into tetrameric complexes expressed on the viral envelope. J. Virol. 78:7969-7983.
4. Asada, H., S. Yalcin, K. Balachandra, K. Higashi, and K. Yamanishi. 1989. Establishment of titration system for human herpesvirus 6 and evaluation of neutralizing antibody response to the virus. J. Clin. Microbiol. 27:2204-2207.
5. Aubin, J. T., et al. 1991. Several groups among human herpesvirus 6 strains can be distinguished by Southern blotting and polymerase chain reaction. J. Clin. Microbiol. 29:367-372.
6. Backovic, M., R. Longnecker, and T. S. Jardetzky. 2009. Structure of a trimeric variant of the Epstein-Barr virus glycoprotein B. Proc. Natl. Acad. Sci. U. S. A. 106:2880-2885.
7. Campadelli-Fiume, G., S. Guerrini, X. Liu, and L. Foa-Tomasi. 1993. Monoclonal antibodies to glycoprotein B differentiate human herpesvirus 6 into two clusters, variants A and B. J. Gen. Virol. 74(Pt. 10):2257-2262.
8. Chandran, B., S. Tirawatnapong, B. Pfeiffer, and D. V. Ablashi. 1992. Antigenic relationships among human herpesvirus-6 isolates. J. Med. Virol. 37:247-254.
9. Chowdary, T. K., et al. 2010. Crystal structure of the conserved herpesvirus fusion regulator complex gH-gL. Nat. Struct. Mol. Biol. 17:882-888.
10. Connolly, S. A., J. O. Jackson, T. S. Jardetzky, and R. Longnecker. 2011. Fusing structure and function: a structural view of the herpesvirus entry machinery. Nat. Rev. Microbiol. 9:369-381.
11. Dhepakson, P., et al. 2002. Human herpesvirus-6 rep/U94 gene product has single-stranded DNA-binding activity. J. Gen. Virol. 83:847-854.
12. Dominguez, G., et al. 1999. Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A. J. Virol. 73:8040-8052.
13. Drobyski, W. R., K. K. Knox, D. Majewski, and D. R. Carrigan. 1994. Fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N. Engl. J. Med. 330:1356-1360.
14. Gentile, I., M. Talamo, and G. Borgia. 2010. Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergymediated viral reactivation? Report of a case and literature review. BMC Infect. Dis. 10:49.
15. Gompels, U. A., et al. 1995. The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology 209:29-51.
16. Hall, C. B., et al. 1994. Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N. Engl. J. Med. 331:432-438.
17. Heldwein, E. E., et al. 2006. Crystal structure of glycoprotein B from herpes simplex virus 1. Science 313:217-220.
18. Hutchinson, L., et al. 1992. A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH. J. Virol. 66:2240-2250.
19. Isegawa, Y., et al. 1999. Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B. J. Virol. 73:8053-8063.
20. Kaye, J. F., U. A. Gompels, and A. C. Minson. 1992. Glycoprotein H of human cytomegalovirus (HCMV) forms a stable complex with the HCMV UL115 gene product. J. Gen. Virol. 73(Pt. 10):2693-2698.
21. Khattar, S. K., S. van Drunen Littel-van den Harke, S. K. Attah-Poku, L. A. Babiuk, and S. K. Tikoo. 1996. Identification and characterization of a bovine herpesvirus-1 (BHV-1) glycoprotein gL which is required for proper antigenicity, processing, and transport of BHV-1 glycoprotein gH. Virology 219:66-76.
22. Koshizuka, T., M. Ota, K. Yamanishi, and Y. Mori. 2010. Characterization of varicella-zoster virus-encoded ORF0 gene-comparison of parental and vaccine strains. Virology 405:280-288.
23. Krummenacher, C., et al. 2005. Structure of unliganded HSV gD reveals a mechanism for receptor-mediated activation of virus entry. EMBO J. 24:4144-4153.
24. Mori, Y. 2009. Recent topics related to human herpesvirus 6 cell tropism. Cell. Microbiol. 11:1001-1006.
25. Mori, Y., P. Akkapaiboon, X. Yang, and K. Yamanishi. 2003. The human herpesvirus 6 U100 gene product is the third component of the gH-gL glycoprotein complex on the viral envelope. J. Virol. 77:2452-2458.
26. Mori, Y., et al. 2004. Discovery of a second form of tripartite complex containing gH-gL of human herpesvirus 6 and observations on CD46. J. Virol. 78:4609-4616.
27. Mori, Y., et al. 2008. Human herpesvirus-6 induces MVB formation, and virus egress occurs by an exosomal release pathway. Traffic 9:1728-1742.
28. Mori, Y., X. Yang, P. Akkapaiboon, T. Okuno, and K. Yamanishi. 2003. Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46. J. Virol. 77:4992-4999.
29. Mullen, M. M., K. M. Haan, R. Longnecker, and T. S. Jardetzky. 2002. Structure of the Epstein-Barr virus gp42 protein bound to the MHC class II receptor HLA-DR1. Mol. Cell 9:375-385.
30. Niwa, H., K. Yamamura, and J. Miyazaki. 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193-199.
31. Okuno, T., et al. 1989. Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J. Clin. Microbiol. 27:651-653.
32. Pfeiffer, B., et al. 1993. Identification and mapping of the gene encoding the glycoprotein complex gp82-gp105 of human herpesvirus 6 and mapping of the neutralizing epitope recognized by monoclonal antibodies. J. Virol. 67:4611-4620.
33. Ryckman, B. J., M. C. Chase, and D. C. Johnson. 2008. HCMV gH/gL/UL128-131 interferes with virus entry into epithelial cells: evidence for cell type-specific receptors. Proc. Natl. Acad. Sci. U. S. A. 105:14118-14123.
34. Ryckman, B. J., M. C. Chase, and D. C. Johnson. 2010. Human cytomegalovirus TR strain glycoprotein O acts as a chaperone promoting gH/gL incorporation into virions but is not present in virions. J. Virol. 84:2597-2609.
35. Ryckman, B. J., et al. 2008. Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells. J. Virol. 82:60-70.
36. Salahuddin, S. Z., et al. 1986. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234:596-601.
37. Santoro, F., et al. 1999. CD46 is a cellular receptor for human herpesvirus 6. Cell 99:817-827.
38. Saxinger, C., et al. 1988. Antibody reactivity with HBLV (HHV-6) in U.S. populations. J. Virol. Methods 21:199-208.
39. Spear, P. G., and R. Longnecker. 2003. Herpesvirus entry: an update. J. Virol. 77:10179-10185.
40. Takeda, K., et al. 1997. Identification of a variant B-specific neutralizing epitope on glycoprotein H of human herpesvirus-6. J. Gen. Virol. 78(Pt. 9):2171-2178.
41. Takeda, K., T. Okuno, Y. Isegawa, and K. Yamanishi. 1996. Identification of a variant A-specific neutralizing epitope on glycoprotein B (gB) of human herpesvirus-6 (HHV-6). Virology 222:176-183.
42. Tang, H., M. Hayashi, T. Maeki, K. Yamanishi, and Y. Mori. 2011. Human herpesvirus 6 glycoprotein complex formation is required for folding and trafficking of the gH/gL/gQ1/gQ2 complex and its cellular receptor binding. J. Virol. 85:11121-11130.
43. Tang, H., et al. 2010. Human herpesvirus 6 encoded glycoprotein Q1 gene is essential for virus growth. Virology 407:360-367.
44. Tang, H., and Y. Mori. 2010. Human herpesvirus-6 entry into host cells. Future Microbiol. 5:1015-1023.
45. Tiacci, E., et al. 2000. Fatal herpesvirus-6 encephalitis in a recipient of a T-cell-depleted peripheral blood stem cell transplant from a 3-loci mismatched related donor. Haematologicaae 85:94-97.
46. Wainwright, M. S., et al. 2001. Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann. Neurol. 50:612-619.
47. Wille, P. T., A. J. Knoche, J. A. Nelson, M. A. Jarvis, and D. C. Johnson. 2010. A human cytomegalovirus gO-null mutant fails to incorporate gH/gL into the virion envelope and is unable to enter fibroblasts and epithelial and endothelial cells. J. Virol. 84:2585-2596.
48. Yamanishi, K., et al. 1988. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet i:1065-1067.
49. Zerr, D. M., et al. 2005. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin. Infect. Dis. 40:932-940.